Colchicine Strides (Colchicine)

Colchicine Strides is indicated for conditions where inflammation is driven by neutrophil activity. It is commonly prescribed for:

• Acute gout flares to reduce pain and swelling.
• Prophylaxis of familial Mediterranean fever attacks.
• Management of other inflammatory conditions as determined by a physician.
• Adjunct therapy when standard treatments are insufficient.
• Situations requiring rapid anti‑inflammatory action.

Colchicine Strides may cause a range of side effects, varying in frequency and severity. Patients should be aware of both common and serious reactions.

Common

• Gastrointestinal upset such as nausea, vomiting, or diarrhea.
• Abdominal cramping or discomfort.
• Mild headache.

Serious

• Severe muscle weakness or myopathy.
• Blood disorders including neutropenia or thrombocytopenia.
• Signs of organ toxicity such as liver or kidney impairment.

Before starting Colchicine Strides, certain precautions should be considered to minimize risk. Patients are advised to discuss the following with their healthcare provider:

• Existing kidney or liver disease that may affect drug clearance.
• Concomitant use of medications that influence colchicine metabolism.
• History of blood disorders or low white blood cell counts.
• Pregnancy or breastfeeding status, as safety data are limited.
• Potential for drug accumulation in older adults.
• Need for regular laboratory monitoring during therapy.

Colchicine Strides can interact with other medicines, altering its effectiveness or increasing toxicity. Interaction management is essential.

Avoid

• Strong CYP3A4 inhibitors such as clarithromycin or ketoconazole.
• P‑glycoprotein inhibitors like verapamil that raise colchicine levels.
• Concurrent use with other colchicine-containing products.

Use with caution

• Statins, especially simvastatin, due to myopathy risk.
• Digoxin, as colchicine may increase serum concentrations.
• Anticoagulants, which may be affected by gastrointestinal side effects.